US patent for mum doc weight loss kit – News2IN
India

US patent for mum doc weight loss kit

Written by news2in

Mumbai: Can the device control the blood flow in such a way that someone loses weight? The head of one of the most prestigious medical schools in the country, Kem Hospital in Parel, recently received a patent for such a concept from the US patent office.
Dean Hemant Deshmukh, a radiologist intervention, think of a device while repairing blood vessels which narrows around the small intestine.
Cardiologists repair ships that narrow around the heart and radiologists Interventions are trained to improve vessels in other parts of the body such as the brain, lungs, feet and stomach, among others, to prevent strokes and gangrene.
“The flow-resistant device itself, the blood flow we planned is about the idea formed,” said Deshmukh.
“As an interventional radiologist, we treat arteries and veins by opening or close them as a demanding situation,” he said.
What is not famous is that plaque buildup does not only affect the heart vessels but even vessels in the stomach.
When the superior mesenteric artery that supplies blood to the small intestine develops blockages, patients begin to suffer from “abdominal angina”.
“The patient developed this angina every time he ate.
As a result, they developed fear of food and avoided it, causing a weight loss of 10 to 20kg,” he said.
This connection between the blocked Mesenteric arteries, Cibophobia and weight loss that he, along with Dr.
Krikumumar Rathod, works.
“We feel we can narrow the mesenteric arteries in obese people by introducing a device like a stent that will trigger weight loss,” he said.
The narrow artery induces Cibophobia, which in turn, causes weight loss.
The doctors apply for a patent in April 2016 and got it earlier this month.
The device they designed in a diameter of 8mm, shaped like a glass clock, and the length is 15mm to 20mm.
“We now have to compile the shipping system, make prototypes and plan animal studies,” he said.
These steps need to be followed before human trials.

About the author

news2in